TrialBlood2024
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.
Zhuoer Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
TrialBlood2024
Zhuoer Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.